ENTRY       D09723                      Drug
NAME        Taspoglutide (USAN/INN)
FORMULA     C152H232N40O45
EXACT_MASS  3337.7095
MOL_WEIGHT  3339.7095
SEQUENCE    His Aib Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly
            Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Aib Arg-NH2
            (-CH3 combined: 2; 29)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01493  GLP-1 receptor agonist
EFFICACY    Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist
COMMENT     Glucagon-like peptide 1 (GLP-1) analog [CPD:C16048]
            Treatment of type 2 diabetes
TARGET      GLP1R [HSA:2740] [KO:K04581]
  PATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction
            hsa04911(2740)  Insulin secretion
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01493  GLP-1 receptor agonist
                D09723  Taspoglutide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GLP1R
                 D09723  Taspoglutide (USAN/INN)
DBLINKS     CAS: 275371-94-3
            PubChem: 124490463
///
